ABB was established in June 1999 and has been collecting the clinical isolates of bacterial pathogens from ANSORP investigators in Asia since then. As of 2008, a total of 33,300 isolates of important bacterial pathogens have been collected from 14 countries and preserved. Through continuous collection and preservation of clinical isolates, ABB will be a representative research resource bank on pathogenic microorganisms in Asian region.

ABB observes the UN Model Regulations, the IATA Dangerous Goods Regulations, the WHO Laboratory Biosafety Manual and other applicable regulations. According to those international regulations, ABB distributes the collected bacterial isolates to investigators in Asian countries. ABB serves the improvement of basic research of microbiology, infectious diseases, and antimicrobial resistances in Asia.